Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04531254
Other study ID # 1000071861
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 10, 2020
Est. completion date August 31, 2020

Study information

Verified date November 2022
Source The Hospital for Sick Children
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This will be a prospective study simulating return to school for two full days prior to the start of the school year in September. Volunteer students and teachers from six grade ranges will be recruited to participate in the study. In each grade range, there will be two classes that will participate, one that will be assigned to wear face masks/coverings at all times (experimental group/class) and the other that will not wear face masks/coverings at all times (control group/class). Students will be randomized to either the masking at all times (experimental across all grades) or no masking (control across JK-Grade 4) / masking only when physical distance can be maintained (control across Grade 5-Grade 12) class in their appropriate grade. Personal behaviours and person-to-person interactions will be recorded using video cameras. In addition, a safe biological indicator will be applied to the hands to simulate potential asymptomatic infection in a subset of students. Other students will have sanitizer applied so that students are blinded to who has the indicator. Cameras will be used to document how the indicator moves throughout the classroom.


Description:

Grade ranges will include 1) Senior Kindergarten (children who have just completed JK or SK in the 2019-2020 year), 2) Grades 1-2, 3) Grades 3-4, 4) Grades 5-6, 5) Grades 7-8 and 6) high school. A total of 14 teachers and up to 240 students will be recruited. Final class sizes will be in accordance with Ministry of Education and public health guidelines.


Recruitment information / eligibility

Status Completed
Enrollment 174
Est. completion date August 31, 2020
Est. primary completion date August 31, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 4 Years to 18 Years
Eligibility Inclusion Criteria: • To be included in the study, students must have attended a structure learning environment during 2019-2020 school year and provide informed consent (student in Grade 7 or older) or parental consent (SK - Grade 6) and assent (if appropriate). To be included in the study, teachers must be certified teachers and provide informed consent to participate. Exclusion Criteria: - require additional resources or support beyond what can be provided by the single class teacher - have been exposed to an individual that has tested positive for COVID-19 in the 14 days prior to the simulation - test positive for COVID-19 in the 14 days prior to the simulation - have signs or symptoms of COVID-19, as identified on the screening form (See Screening Form) before the simulations - travel outside Canada in the last 14 days - known hypersensitivity or allergy to the biological indicator (Fluorescein dye/GloGerm)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Wearing a face mask at all times
Children in this group will be asked to wear a face mask in the classroom and common areas during the simulation

Locations

Country Name City State
Canada The Hospital for Sick Children Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
The Hospital for Sick Children

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Total number of hand-to-face contacts per participant per hour The number of touches to the face made per hour in the simulated school environment Day 2
Secondary Total number of hand-to-mucus membrane contacts per participant per hour The number of touches to the eyes, nose, mouth made per hour in the simulated school environment Day 2
Secondary Total number of hand-to-non-mucus membrane contacts per participant per hour The number of touches to the skin (not eyes, nose, mouth) made per hour in the simulated school environment Day 2
Secondary Total number of instances where participants are within 1 and 2 meters of each other The number of instances where 1 and 2 meter distance between participants is breached in the classroom Day 2
Secondary Total number of glo germ transfers to another person The number of children within a classroom with Glo Germ on the hands/face Day 2
Secondary Total number of glo germ transfers to teacher The presence of Glo Germ on the hands/face of teacher within the same classroom Day 2
Secondary Total number of glo germ transfers to a surface The number of surfaces in the classroom with Glo Germ Day 2
Secondary Total number of instances of hand holding per participant per hour The count of hand holding instances with another person per hour in the simulated school environment Day 2
Secondary Total number of touches to another person per participant per hour The count of touches to another person per hour in the simulated school environment Day 2
Secondary Total number of hand hygiene actions per participant per hour The count of hand hygiene actions (i.e., hand washing, hand sanitizer) per participant per hour Day 2
Secondary Total number of mask removals per participant per hour The number of times a participant in a masking group removes their mask per hour in the simulated school environment Day 2
Secondary Teacher concerns measured using study-specific post-simulation questionnaire A study specific questionnaire that examines teacher anxiety and mental health Day 2
Secondary Teacher concerns measured using semi-structured group interviews A study specific semi-structured interview examining the factors throughout the day (hand hygiene, mask use, physical distancing) that impacted the teaching experience Day 2
Secondary Student concerns measured using study-specific post-simulation questionnaire A study specific questionnaire that examines student anxiety and mental health Day 2
Secondary Student concerns measured using semi-structured group interviews A study specific semi-structured interview examining the factors throughout the day (hand hygiene, mask use, physical distancing) that impacted the learning experience Day 2
Secondary Identify activity types that influence touching behaviour The count of each type of activity participants are engaged in while touching others or surfaces in the simulated school environment Day 2
See also
  Status Clinical Trial Phase
Completed NCT05047692 - Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers Phase 1
Recruiting NCT04395768 - International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 Phase 2
Completed NCT04508777 - COVID SAFE: COVID-19 Screening Assessment for Exposure
Completed NCT04506268 - COVID-19 SAFE Enrollment N/A
Terminated NCT04555096 - A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 Phase 2
Completed NCT04961541 - Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine Phase 1/Phase 2
Active, not recruiting NCT04546737 - Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients N/A
Completed NCT04532294 - Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants Phase 1
Completed NCT04494646 - BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) Phase 2
Terminated NCT04542993 - Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy Phase 2
Not yet recruiting NCT04543006 - Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19 N/A
Terminated NCT04581915 - PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 Phase 2/Phase 3
Completed NCT04537663 - Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults Phase 4
Completed NCT04387292 - Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Not yet recruiting NCT04527211 - Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel Phase 3
Not yet recruiting NCT05038449 - Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19 N/A
Completed NCT04979858 - Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask N/A
Completed NCT04610502 - Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients Phase 2
Active, not recruiting NCT06042855 - ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) Phase 3